Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Corporation (INTC) -- Ignore unavailable to you. Want to Upgrade?

To: TimF who wrote (183420)	2/3/2006 7:26:05 PM
From: Road Walker	Read Replies (2) \| Respond to of 186894

re: The drug market didn't organize itself that way. Countries governments organized themselves that way and imposed that preference on the market. The customer determines the market, and the governments are the largest market. re: The foreign countries distort the market with price controls (both direct controls, and indirect actions that effectively function as controls). The US has an open internal market (with the exception of patent rights that the other countries also have). There are large organizations in every marketplace that get advantages that individuals do not get. The "foreign countries" that "distort" the market ARE the market, like it or not. We may have an "open internal market" but it is forcefully manipulated by our law, and is obviously inferior. The "foreign" (the rest of the world) markets have a better solution. We are getting screwed. re: The idea of an "open market" that has price controls doesn't make sense. You have to get rid of the price controls to really have an open market. Forget "price controls", they have cost leverage. A function of open markets. For some <political> reason we've decided to give the domestic leverage to the drug companies.